Cargando…

Early lyophilized cryoprecipitate enhances the ADAMTS13/VWF ratio to reduce systemic endotheliopathy and lessen lung injury in a mouse multiple-trauma hemorrhage model

Recent studies in severely injured patients suggest an important role of von Willebrand Factor (VWF) and ADAMTS13 in the endotheliopathy of trauma (EoT). We hypothesized that the early use of cryoprecipitate would be effective as an endothelial protector by supplementing physiologic VWF and ADAMTS13...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeineddin, Ahmad, Wu, Feng, Dong, Jing-Fei, Vesselinov, Roumen, Neal, Matthew D., Corash, Laurence, Pati, Shibani, Kozar, Rosemary A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389395/
https://www.ncbi.nlm.nih.gov/pubmed/37211640
http://dx.doi.org/10.1097/TA.0000000000004065
_version_ 1785082290551914496
author Zeineddin, Ahmad
Wu, Feng
Dong, Jing-Fei
Vesselinov, Roumen
Neal, Matthew D.
Corash, Laurence
Pati, Shibani
Kozar, Rosemary A.
author_facet Zeineddin, Ahmad
Wu, Feng
Dong, Jing-Fei
Vesselinov, Roumen
Neal, Matthew D.
Corash, Laurence
Pati, Shibani
Kozar, Rosemary A.
author_sort Zeineddin, Ahmad
collection PubMed
description Recent studies in severely injured patients suggest an important role of von Willebrand Factor (VWF) and ADAMTS13 in the endotheliopathy of trauma (EoT). We hypothesized that the early use of cryoprecipitate would be effective as an endothelial protector by supplementing physiologic VWF and ADAMTS13 to reverse the EoT. We tested a pathogen-reduced lyophilized cryoprecipitate (LPRC) that could expedite the early administration of cryoprecipitate in the battlefield. METHODS: A mouse multiple-trauma model with uncontrolled hemorrhage (UCH) from liver injury was utilized followed by hypotensive resuscitation (mean arterial pressure, 55–60) × 3 hours with lactated Ringer's (LR), fresh frozen plasma (FFP), conventional pathogen-reduced cryoprecipitate (CC), and LPRC. Blood was collected for measurement of syndecan-1, VWF, and ADAMTS13 by ELISA. Lungs were stained for histopathologic injury and syndecan-1 and bronchial alveolar lavage (BAL) fluid harvested for protein as an indicator of permeability. Statistical analysis was by ANOVA followed by Bonferroni correction. RESULTS: Following multiple trauma and UCH, blood loss was similar across groups. Mean volume of resuscitation was higher in the LR group compared with the other resuscitation groups. Lung histopathologic injury, syndecan-1 immunostaining and BAL protein were higher with LR compared with resuscitation with FFP and CC, while LPRC further reduced BAL compared with FFP and CC. The ADAMTS13/VWF ratio was significantly lower in LR but improved with FFP and CC, comparable to shams while LPRC further increased this ratio. CONCLUSION: The protective effects of CC and LPRC were comparable to FFP in ameliorating the EoT in our murine multiple trauma and UCH model. Lyophilized cryoprecipitate may also provide additional benefit by enhancing the ADAMTS13/VWF ratio. These data provide evidence of the safety and efficacy of LPRC and warrants further investigation for its potential application in military settings once approved for human administration.
format Online
Article
Text
id pubmed-10389395
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-103893952023-08-01 Early lyophilized cryoprecipitate enhances the ADAMTS13/VWF ratio to reduce systemic endotheliopathy and lessen lung injury in a mouse multiple-trauma hemorrhage model Zeineddin, Ahmad Wu, Feng Dong, Jing-Fei Vesselinov, Roumen Neal, Matthew D. Corash, Laurence Pati, Shibani Kozar, Rosemary A. J Trauma Acute Care Surg Original Articles Recent studies in severely injured patients suggest an important role of von Willebrand Factor (VWF) and ADAMTS13 in the endotheliopathy of trauma (EoT). We hypothesized that the early use of cryoprecipitate would be effective as an endothelial protector by supplementing physiologic VWF and ADAMTS13 to reverse the EoT. We tested a pathogen-reduced lyophilized cryoprecipitate (LPRC) that could expedite the early administration of cryoprecipitate in the battlefield. METHODS: A mouse multiple-trauma model with uncontrolled hemorrhage (UCH) from liver injury was utilized followed by hypotensive resuscitation (mean arterial pressure, 55–60) × 3 hours with lactated Ringer's (LR), fresh frozen plasma (FFP), conventional pathogen-reduced cryoprecipitate (CC), and LPRC. Blood was collected for measurement of syndecan-1, VWF, and ADAMTS13 by ELISA. Lungs were stained for histopathologic injury and syndecan-1 and bronchial alveolar lavage (BAL) fluid harvested for protein as an indicator of permeability. Statistical analysis was by ANOVA followed by Bonferroni correction. RESULTS: Following multiple trauma and UCH, blood loss was similar across groups. Mean volume of resuscitation was higher in the LR group compared with the other resuscitation groups. Lung histopathologic injury, syndecan-1 immunostaining and BAL protein were higher with LR compared with resuscitation with FFP and CC, while LPRC further reduced BAL compared with FFP and CC. The ADAMTS13/VWF ratio was significantly lower in LR but improved with FFP and CC, comparable to shams while LPRC further increased this ratio. CONCLUSION: The protective effects of CC and LPRC were comparable to FFP in ameliorating the EoT in our murine multiple trauma and UCH model. Lyophilized cryoprecipitate may also provide additional benefit by enhancing the ADAMTS13/VWF ratio. These data provide evidence of the safety and efficacy of LPRC and warrants further investigation for its potential application in military settings once approved for human administration. Lippincott Williams & Wilkins 2023-08 2023-05-22 /pmc/articles/PMC10389395/ /pubmed/37211640 http://dx.doi.org/10.1097/TA.0000000000004065 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Zeineddin, Ahmad
Wu, Feng
Dong, Jing-Fei
Vesselinov, Roumen
Neal, Matthew D.
Corash, Laurence
Pati, Shibani
Kozar, Rosemary A.
Early lyophilized cryoprecipitate enhances the ADAMTS13/VWF ratio to reduce systemic endotheliopathy and lessen lung injury in a mouse multiple-trauma hemorrhage model
title Early lyophilized cryoprecipitate enhances the ADAMTS13/VWF ratio to reduce systemic endotheliopathy and lessen lung injury in a mouse multiple-trauma hemorrhage model
title_full Early lyophilized cryoprecipitate enhances the ADAMTS13/VWF ratio to reduce systemic endotheliopathy and lessen lung injury in a mouse multiple-trauma hemorrhage model
title_fullStr Early lyophilized cryoprecipitate enhances the ADAMTS13/VWF ratio to reduce systemic endotheliopathy and lessen lung injury in a mouse multiple-trauma hemorrhage model
title_full_unstemmed Early lyophilized cryoprecipitate enhances the ADAMTS13/VWF ratio to reduce systemic endotheliopathy and lessen lung injury in a mouse multiple-trauma hemorrhage model
title_short Early lyophilized cryoprecipitate enhances the ADAMTS13/VWF ratio to reduce systemic endotheliopathy and lessen lung injury in a mouse multiple-trauma hemorrhage model
title_sort early lyophilized cryoprecipitate enhances the adamts13/vwf ratio to reduce systemic endotheliopathy and lessen lung injury in a mouse multiple-trauma hemorrhage model
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389395/
https://www.ncbi.nlm.nih.gov/pubmed/37211640
http://dx.doi.org/10.1097/TA.0000000000004065
work_keys_str_mv AT zeineddinahmad earlylyophilizedcryoprecipitateenhancestheadamts13vwfratiotoreducesystemicendotheliopathyandlessenlunginjuryinamousemultipletraumahemorrhagemodel
AT wufeng earlylyophilizedcryoprecipitateenhancestheadamts13vwfratiotoreducesystemicendotheliopathyandlessenlunginjuryinamousemultipletraumahemorrhagemodel
AT dongjingfei earlylyophilizedcryoprecipitateenhancestheadamts13vwfratiotoreducesystemicendotheliopathyandlessenlunginjuryinamousemultipletraumahemorrhagemodel
AT vesselinovroumen earlylyophilizedcryoprecipitateenhancestheadamts13vwfratiotoreducesystemicendotheliopathyandlessenlunginjuryinamousemultipletraumahemorrhagemodel
AT nealmatthewd earlylyophilizedcryoprecipitateenhancestheadamts13vwfratiotoreducesystemicendotheliopathyandlessenlunginjuryinamousemultipletraumahemorrhagemodel
AT corashlaurence earlylyophilizedcryoprecipitateenhancestheadamts13vwfratiotoreducesystemicendotheliopathyandlessenlunginjuryinamousemultipletraumahemorrhagemodel
AT patishibani earlylyophilizedcryoprecipitateenhancestheadamts13vwfratiotoreducesystemicendotheliopathyandlessenlunginjuryinamousemultipletraumahemorrhagemodel
AT kozarrosemarya earlylyophilizedcryoprecipitateenhancestheadamts13vwfratiotoreducesystemicendotheliopathyandlessenlunginjuryinamousemultipletraumahemorrhagemodel